Thursday, November 12, 2026

USD/EUR Bearish Momentum With A 1% Slide In The Last 21 Sessions

USD/EUR Bearish Momentum With A 1% Slide In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.88% for the last 21 sessions. At 02:12 EST on Friday, 23 June, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 1.475% up from its 52-week low and 12.736% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a negative 0.08%, and a positive 0.36%, respectively.

USD/EUR's highest amplitude of average volatility was 0.38% (last week), 0.33% (last month), and 0.36% (last quarter), respectively.

News about

  • Usd/jpy: 200-dma near 138/137.20 expected to provide support – socgen. According to FXStreet on Wednesday, 21 June, "Economists at Société Générale analyze USD/JPY technical outlook."
  • Usd/jpy bounces off 100-hour sma, trades with a mild positive bias above mid-141.00s. According to FXStreet on Wednesday, 21 June, "This, in turn, should help investors to determine the near-term trajectory for the USD/JPY pair. ", "The USD/JPY pair struggles to gain any meaningful traction on Wednesday and oscillates in a narrow trading band, just above the mid-141.00s through the Asian session. "
  • Usd/jpy technical analysis: Jerome Powell determines fate - 21 June 2023. According to DailyForex on Wednesday, 21 June, "The continuation of the clear divergence between the policy of the Japanese Central Bank's indulgent policy and the Federal Reserve Bank, which is leading a fierce campaign of tightening to contain record inflation, will remain supportive of the bullish trend of the USD/JPY currency pair. ", "Dollar expectations against the yen today:Despite the recent profit-taking sales, the general direction of the USD/JPY currency pair is still bullish."
  • Usd/jpy remains on the defensive below 142.00 mark, downside seems limited. According to FXStreet on Thursday, 22 June, "Apart from this, a more dovish stance adopted by the Bank of Japan (JPY) continues to undermine the Japanese Yen (JPY) and holds back bearish traders from placing aggressive bets around the USD/JPY pair.", "The USD/JPY pair edges lower during the Asian session on Thursday and moves away from a fresh high since November 2022, around the 142.35 area touched the previous day. "
  • Usd/jpy climbs above 142.00 as US dollar stays firm, fed powell’s testimony eyed. According to FXStreet on Wednesday, 21 June, "The USD/JPY pair has quickly jumped above 142.00 as the US Dollar has remained firm in the European session. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com